RNAv8
Biotechnology company developing RNA logic gate screening platforms for precision medicine, enabling cell-specific therapeutic targeting across any indication.
Notes
RNAv8 is a biotechnology company developing innovative RNA logic gate technologies for precision medicine applications. Based in Boston, Massachusetts, the company's platform enables the creation of RNA-based circuits that can sense cellular conditions and activate therapeutic payloads only in specific cell types or disease states.
The company's screening platform allows for the identification of RNA logic gates that can discriminate between healthy and diseased cells, enabling highly targeted therapeutic approaches with reduced off-target effects. This technology has potential applications across a wide range of indications.
RNAv8 is part of the Portal Innovations portfolio and is currently in pre-clinical development.
Team
- Devan Shah - Founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/devanshah
Additional Research Findings
- Portfolio company of Portal Innovations
- Stage: Pre-clinical
- RNA logic gate technology platform
- Screening platform for cell-specific targeting
- Applications across multiple therapeutic areas
- Boston, Massachusetts headquarters
- Founded by Devan Shah
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Portal Innovations | US | biotech-focused | - | 13 |